ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

CC6 Is it truly pulmonary arterial hypertension?

Challenging clinical cases
Chairs: O. Sitbon (Le Kremlin-Bicêtre, France)
Aims: Access educational materials here
The diagnosis of pulmonary arterial hypertension is becoming more complex because patients present with more comorbidities. These comorbidities range from metabolic syndrome to coronary artery disease and/or mild lung parenchymal diseases. The aim of this session is to present three different cases of patients who were referred for treatment of PAH that may have developed via different pathophysiological mechanisms.

Download all media

Case 1: Is it lung parenchyma-associated pulmonary hypertension or PAH? J. Barberà (Barcelona, Spain)
Case 2: Is it left ventricular dysfunction or PAH? J. Vachiery (Bruxelles, Belgium)
Case 3: Is it a systemic disorder or PAH? S. Gaine (Dublin, Ireland)